{"id":10066,"date":"2019-02-06T10:17:15","date_gmt":"2019-02-06T09:17:15","guid":{"rendered":"https:\/\/www.umweltperspektiven.ch\/?p=1997"},"modified":"2022-02-09T11:10:08","modified_gmt":"2022-02-09T10:10:08","slug":"neuer-fonds-im-namen-der-onkologie-forschung","status":"publish","type":"post","link":"https:\/\/www.organisator.ch\/it\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/","title":{"rendered":"Nuovo fondo in nome della ricerca oncologica"},"content":{"rendered":"<figure id=\"attachment_1999\" aria-describedby=\"caption-attachment-1999\" style=\"width: 680px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1999 size-medium\" src=\"\/\/www.umweltperspektiven.ch\/wp-content\/uploads\/2019\/02\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven.jpg\" alt=\"\" width=\"680\" height=\"850\" \/><figcaption id=\"caption-attachment-1999\" class=\"wp-caption-text\">Rudi Van den Eynde, responsabile del settore azionario tematico di Candriam. (Immagine: zVg)<\/figcaption><\/figure>\n<p>Il Candriam Fund (LU1864481467) investe in societ\u00e0 quotate che sviluppano prodotti e servizi per la diagnosi e il trattamento del cancro. La scienza ha fatto alcuni progressi in oncologia, ma le prospettive per i pazienti di cancro sono spesso ancora scarse. Il cancro \u00e8 la seconda causa di morte nel mondo. Statisticamente, il 40% di tutti gli uomini e le donne ricevono una diagnosi di cancro ad un certo punto della loro vita. Entro il 2030, il numero di morti per cancro in tutto il mondo dovrebbe aumentare del 60%, da otto a 13 milioni all'anno (vedi fonte 2).<\/p>\n<p><strong>Speranze per le innovazioni mediche <\/strong><br \/>\nImmunoterapia, terapia mirata, biopsia liquida, sequenziamento del genoma tumorale, nanotecnologia, chirurgia robotica, intelligenza artificiale e Big Data - ogni giorno i progressi della medicina danno nuove speranze ai malati di cancro e alle loro famiglie. Ma le innovazioni nel trattamento del cancro hanno anche un impatto su molti altri settori, come la biotecnologia, la farmaceutica, l'intelligenza artificiale e la ricerca, cos\u00ec come sulle aziende di tutto il mondo.<\/p>\n<p>Candriam Equities L Oncology Impact sostiene lo sviluppo di molti nuovi approcci alla diagnosi e al trattamento del cancro. L'obiettivo \u00e8 quello di investire in innovazioni rivoluzionarie che migliorino significativamente il trattamento della malattia.<\/p>\n<p>Rudi Van den Eynde, Head of Thematic Equity di Candriam dice: \"Ci sono molti progressi nel trattamento di molte malattie, soprattutto il cancro. Vogliamo investire in aziende con un forte potenziale di crescita. Con la nostra competenza e vent'anni di esperienza nella gestione di un fondo biotecnologico, siamo molto ben posizionati per farlo. Il team include due analisti di dottorato ed \u00e8 anche supportato da un gruppo consultivo indipendente di importanti ricercatori sul cancro\".<\/p>\n<p><strong>Previsto un alto beneficio per la societ\u00e0<\/strong><\/p>\n<p>Vincent Hamelink, Chief Investment Officer di Investment Management aggiunge: \"I nuovi trattamenti e le tecnologie innovative continueranno a far crescere il mercato oncologico internazionale. Il nostro nuovo Candriam Equities L Oncology Impact \u00e8 progettato per generare rendimenti per gli investitori, sostenendo allo stesso tempo la ricerca sul cancro - creando importanti benefici sociali. Aumentando il nostro coinvolgimento in questo settore e donando anche il dieci per cento della commissione di gestione del fondo, vogliamo partecipare direttamente alla lotta contro il cancro\".<\/p>\n<p>Candriam Equities L Oncology Impact \u00e8 un comparto di Candriam Equities L, una SICAV lussemburghese (Soci\u00e9t\u00e9 d'investissement \u00e0 capital variable) gestita da Candriam Luxembourg. Il Fondo \u00e8 attualmente autorizzato alla distribuzione nei seguenti paesi: Austria, Francia, Germania, Italia, Lussemburgo, Paesi Bassi, Portogallo, Spagna, Svizzera e Regno Unito. Candriam, l'innovativo asset manager europeo gestisce gi\u00e0 un patrimonio di oltre tre miliardi di euro nelle sue strategie di biotecnologia, robotica e demografia.<\/p>\n<p><a href=\"\/\/www.candriam.com\">www.candriam.com<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><em>2 Fonti: Istituto Nazionale della Salute (NIH) e Organizzazione Mondiale della Sanit\u00e0 (OMS)<\/em><\/p>\n<p><em>Nota generale: al fine di comprendere appieno il profilo di rischio del Fondo, Candriam raccomanda agli investitori di leggere attentamente il prospetto ufficiale e la descrizione dei rischi. Il prospetto, le ultime relazioni annuali e semestrali e altre informazioni importanti sul fondo sono disponibili in inglese o nella lingua dei paesi in cui il fondo \u00e8 autorizzato alla distribuzione.\u00a0<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Der Candriam Fonds (LU1864481467) investiert in b\u00f6rsennotierte Unternehmen, die Produkte und Dienstleistungen zur Diagnose und Behandlung von Krebs entwickeln. Die Wissenschaft hat in der Onkologie einige Fortschritte erzielt, gleichwohl sind die Aussichten f\u00fcr Krebspatienten oft immer noch schlecht. Krebs ist die weltweit zweith\u00e4ufigste Todesursache. Statistisch gesehen erhalten 40 Prozent aller M\u00e4nner und Frauen irgendwann in [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":9583,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_yoast_wpseo_focuskw":"Candriam","_yoast_wpseo_metadesc":"Candriam hat zum Weltkrebstag 2019 die Auflage des thematischen Aktienfonds Candriam Equities L Oncology Impact bekannt gegeben.","articlekey":"","footnotes":""},"categories":[580],"tags":[1206,274,1442,1679,1873],"class_list":["post-10066","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sustainability","tag-fonds","tag-innovation","tag-investment","tag-medizin","tag-onkologie"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Neuer Fonds im Namen der Onkologie-Forschung - Organisator<\/title>\n<meta name=\"description\" content=\"Candriam hat zum Weltkrebstag 2019 die Auflage des thematischen Aktienfonds Candriam Equities L Oncology Impact bekannt gegeben.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.organisator.ch\/it\/sostenibilita\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neuer Fonds im Namen der Onkologie-Forschung - Organisator\" \/>\n<meta property=\"og:description\" content=\"Candriam hat zum Weltkrebstag 2019 die Auflage des thematischen Aktienfonds Candriam Equities L Oncology Impact bekannt gegeben.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.organisator.ch\/it\/sostenibilita\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/\" \/>\n<meta property=\"og:site_name\" content=\"Organisator\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/OrganisatorFachmagazin\" \/>\n<meta property=\"article:published_time\" content=\"2019-02-06T09:17:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-09T10:10:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.organisator.ch\/wp-content\/uploads\/2019\/02\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2047\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"michael.merz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/\"},\"author\":{\"name\":\"michael.merz\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#\\\/schema\\\/person\\\/134708ca9321c57b0362cceb7948ffbd\"},\"headline\":\"Neuer Fonds im Namen der Onkologie-Forschung\",\"datePublished\":\"2019-02-06T09:17:15+00:00\",\"dateModified\":\"2022-02-09T10:10:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/\"},\"wordCount\":508,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg\",\"keywords\":[\"Fonds\",\"Innovation\",\"Investment\",\"Medizin\",\"Onkologie\"],\"articleSection\":[\"SUSTAINABILITY\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/\",\"url\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/\",\"name\":\"Neuer Fonds im Namen der Onkologie-Forschung - Organisator\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg\",\"datePublished\":\"2019-02-06T09:17:15+00:00\",\"dateModified\":\"2022-02-09T10:10:08+00:00\",\"description\":\"Candriam hat zum Weltkrebstag 2019 die Auflage des thematischen Aktienfonds Candriam Equities L Oncology Impact bekannt gegeben.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg\",\"width\":2047,\"height\":2560,\"caption\":\"Rudi Van den Eynde, Head of Thematic Equity bei Candriam. (Bild: zVg)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.organisator.ch\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neuer Fonds im Namen der Onkologie-Forschung\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#website\",\"url\":\"https:\\\/\\\/www.organisator.ch\\\/\",\"name\":\"Organisator\",\"description\":\"Kompetent. Praxisnah. Der ORGANISATOR bereitet in 10 Ausgaben pro Jahr die wesentlichen Themen f\u00fcr F\u00fchrungskr\u00e4fte von KMU auf.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.organisator.ch\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#organization\",\"name\":\"Organisator\",\"url\":\"https:\\\/\\\/www.organisator.ch\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/Logo_Organisator_Website.png\",\"contentUrl\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/Logo_Organisator_Website.png\",\"width\":800,\"height\":77,\"caption\":\"Organisator\"},\"image\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/OrganisatorFachmagazin\",\"https:\\\/\\\/www.linkedin.com\\\/showcase\\\/organisator-das-magazin-fr-kmu\",\"https:\\\/\\\/www.xing.com\\\/news\\\/pages\\\/organisator-ch-695\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCGP2Sq0iWaZwT3BdIAQFYpw\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#\\\/schema\\\/person\\\/134708ca9321c57b0362cceb7948ffbd\",\"name\":\"michael.merz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"caption\":\"michael.merz\"},\"url\":\"https:\\\/\\\/www.organisator.ch\\\/it\\\/author\\\/michael-merz\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nuovo fondo in nome della ricerca oncologica - Organizzatore","description":"Candriam ha annunciato il lancio del fondo azionario tematico Candriam Equities L Oncology Impact in occasione della Giornata mondiale del cancro 2019.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.organisator.ch\/it\/sostenibilita\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/","og_locale":"it_IT","og_type":"article","og_title":"Neuer Fonds im Namen der Onkologie-Forschung - Organisator","og_description":"Candriam hat zum Weltkrebstag 2019 die Auflage des thematischen Aktienfonds Candriam Equities L Oncology Impact bekannt gegeben.","og_url":"https:\/\/www.organisator.ch\/it\/sostenibilita\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/","og_site_name":"Organisator","article_publisher":"https:\/\/www.facebook.com\/OrganisatorFachmagazin","article_published_time":"2019-02-06T09:17:15+00:00","article_modified_time":"2022-02-09T10:10:08+00:00","og_image":[{"width":2047,"height":2560,"url":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2019\/02\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg","type":"image\/jpeg"}],"author":"michael.merz","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/#article","isPartOf":{"@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/"},"author":{"name":"michael.merz","@id":"https:\/\/www.organisator.ch\/#\/schema\/person\/134708ca9321c57b0362cceb7948ffbd"},"headline":"Neuer Fonds im Namen der Onkologie-Forschung","datePublished":"2019-02-06T09:17:15+00:00","dateModified":"2022-02-09T10:10:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/"},"wordCount":508,"commentCount":0,"publisher":{"@id":"https:\/\/www.organisator.ch\/#organization"},"image":{"@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/#primaryimage"},"thumbnailUrl":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2019\/02\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg","keywords":["Fonds","Innovation","Investment","Medizin","Onkologie"],"articleSection":["SUSTAINABILITY"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/","url":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/","name":"Nuovo fondo in nome della ricerca oncologica - Organizzatore","isPartOf":{"@id":"https:\/\/www.organisator.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/#primaryimage"},"image":{"@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/#primaryimage"},"thumbnailUrl":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2019\/02\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg","datePublished":"2019-02-06T09:17:15+00:00","dateModified":"2022-02-09T10:10:08+00:00","description":"Candriam ha annunciato il lancio del fondo azionario tematico Candriam Equities L Oncology Impact in occasione della Giornata mondiale del cancro 2019.","breadcrumb":{"@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/#primaryimage","url":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2019\/02\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg","contentUrl":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2019\/02\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg","width":2047,"height":2560,"caption":"Rudi Van den Eynde, Head of Thematic Equity bei Candriam. (Bild: zVg)"},{"@type":"BreadcrumbList","@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.organisator.ch\/"},{"@type":"ListItem","position":2,"name":"Neuer Fonds im Namen der Onkologie-Forschung"}]},{"@type":"WebSite","@id":"https:\/\/www.organisator.ch\/#website","url":"https:\/\/www.organisator.ch\/","name":"Organizzatore","description":"Competente. Pratico. In 10 numeri all'anno, ORGANISATOR presenta i temi essenziali per i manager delle PMI.","publisher":{"@id":"https:\/\/www.organisator.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.organisator.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.organisator.ch\/#organization","name":"Organizzatore","url":"https:\/\/www.organisator.ch\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.organisator.ch\/#\/schema\/logo\/image\/","url":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2022\/01\/Logo_Organisator_Website.png","contentUrl":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2022\/01\/Logo_Organisator_Website.png","width":800,"height":77,"caption":"Organisator"},"image":{"@id":"https:\/\/www.organisator.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/OrganisatorFachmagazin","https:\/\/www.linkedin.com\/showcase\/organisator-das-magazin-fr-kmu","https:\/\/www.xing.com\/news\/pages\/organisator-ch-695","https:\/\/www.youtube.com\/channel\/UCGP2Sq0iWaZwT3BdIAQFYpw"]},{"@type":"Person","@id":"https:\/\/www.organisator.ch\/#\/schema\/person\/134708ca9321c57b0362cceb7948ffbd","name":"michael.merz","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","caption":"michael.merz"},"url":"https:\/\/www.organisator.ch\/it\/author\/michael-merz\/"}]}},"_links":{"self":[{"href":"https:\/\/www.organisator.ch\/it\/wp-json\/wp\/v2\/posts\/10066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.organisator.ch\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.organisator.ch\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.organisator.ch\/it\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.organisator.ch\/it\/wp-json\/wp\/v2\/comments?post=10066"}],"version-history":[{"count":1,"href":"https:\/\/www.organisator.ch\/it\/wp-json\/wp\/v2\/posts\/10066\/revisions"}],"predecessor-version":[{"id":10911,"href":"https:\/\/www.organisator.ch\/it\/wp-json\/wp\/v2\/posts\/10066\/revisions\/10911"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.organisator.ch\/it\/wp-json\/wp\/v2\/media\/9583"}],"wp:attachment":[{"href":"https:\/\/www.organisator.ch\/it\/wp-json\/wp\/v2\/media?parent=10066"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.organisator.ch\/it\/wp-json\/wp\/v2\/categories?post=10066"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.organisator.ch\/it\/wp-json\/wp\/v2\/tags?post=10066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}